November 2026
M	T	W	T	F	S	S
	1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30

Isabelle Grenier-Pleau: Targeting Von Willebrand Disease to Transform Women’s Health

Isabelle Grenier-Pleau/LinkedIn

Sep 23, 2026, 07:28

Isabelle Grenier-Pleau: Targeting Von Willebrand Disease to Transform Women’s Health

Isabelle Grenier-Pleau, Partnerships Development Coordinator at Queen’s Partnerships and Innovation, shared a post on LinkedIn:

“Did you know that Von Willebrand Disease (VWD) is the most common inherited bleeding disorder and it hits women especially hard through heavy menstrual bleeding (HMB).

Women with HMB are at increased risk for anaemia, pain during menstruation, hospitalizations, blood transfusions, limitations in daily activities, time lost from work or school, and a reduced quality of life. They are also three times as likely to have a hysterectomy.

It’s Time Women’s Health Is Top Priority.

Using ancestral sequence reconstruction, Queen’s University researchers Philip Zakas and David Lillicrap, in partnership with researchers from Emory University and Georgia Tech Research, have engineered novel recombinant vWF variants.

The impact of this work would be the development of an at-home best-in-class treatment with prophylactic coverage that extends beyond the menstrual cycle.

Contact me or Queen’s Partnerships and Innovation to learn more about the opportunity.”

Isabelle Grenier-Pleau: Targeting Von Willebrand Disease to Transform Women's Health